254 related articles for article (PubMed ID: 34067609)
21. Tailored or adapted interventions for adults with chronic obstructive pulmonary disease and at least one other long-term condition: a mixed methods review.
Dennett EJ; Janjua S; Stovold E; Harrison SL; McDonnell MJ; Holland AE
Cochrane Database Syst Rev; 2021 Jul; 7(7):CD013384. PubMed ID: 34309831
[TBL] [Abstract][Full Text] [Related]
22. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
23. Chemical composition and therapeutic mechanism of Xuanbai Chengqi Decoction in the treatment of COVID-19 by network pharmacology, molecular docking and molecular dynamic analysis.
Fan L; Feng S; Wang T; Ding X; An X; Wang Z; Zhou K; Wang M; Zhai X; Li Y
Mol Divers; 2023 Feb; 27(1):81-102. PubMed ID: 35258759
[TBL] [Abstract][Full Text] [Related]
24. Organ-specific or personalized treatment for COVID-19: rationale, evidence, and potential candidates.
Mousavi SZ; Rahmanian M; Sami A
Funct Integr Genomics; 2022 Jun; 22(3):429-433. PubMed ID: 35290538
[TBL] [Abstract][Full Text] [Related]
25. A Practical Strategy for Exploring the Pharmacological Mechanism of Luteolin Against COVID-19/Asthma Comorbidity: Findings of System Pharmacology and Bioinformatics Analysis.
Xie YZ; Peng CW; Su ZQ; Huang HT; Liu XH; Zhan SF; Huang XF
Front Immunol; 2021; 12():769011. PubMed ID: 35069542
[TBL] [Abstract][Full Text] [Related]
26. The therapeutic landscape for COVID-19 and post-COVID-19 medications from genetic profiling of the Vietnamese population and a predictive model of drug-drug interaction for comorbid COVID-19 patients.
Nguyen TK; Vu GM; Duong VC; Pham TL; Nguyen NT; Tran TTH; Tran MH; Nguyen DT; Vo NS; Phung HT; Hoang TH
Heliyon; 2024 Mar; 10(6):e27043. PubMed ID: 38509882
[TBL] [Abstract][Full Text] [Related]
27. Differential Co-Expression Network Analysis Reveals Key Hub-High Traffic Genes as Potential Therapeutic Targets for COVID-19 Pandemic.
Hasankhani A; Bahrami A; Sheybani N; Aria B; Hemati B; Fatehi F; Ghaem Maghami Farahani H; Javanmard G; Rezaee M; Kastelic JP; Barkema HW
Front Immunol; 2021; 12():789317. PubMed ID: 34975885
[TBL] [Abstract][Full Text] [Related]
28. SAveRUNNER: A network-based algorithm for drug repurposing and its application to COVID-19.
Fiscon G; Conte F; Farina L; Paci P
PLoS Comput Biol; 2021 Feb; 17(2):e1008686. PubMed ID: 33544720
[TBL] [Abstract][Full Text] [Related]
29. Mortality of COVID-19 is associated with comorbidity in patients with chronic obstructive pulmonary disease.
Andreen N; Andersson LM; Sundell N; Gustavsson L; Westin J
Infect Dis (Lond); 2022 Jul; 54(7):508-513. PubMed ID: 35287524
[TBL] [Abstract][Full Text] [Related]
30. Deciphering the molecular mechanism and crosstalk between Parkinson's disease and breast cancer through multi-omics and drug repurposing approach.
Advani D; Kumar P
Neuropeptides; 2022 Dec; 96():102283. PubMed ID: 35994781
[TBL] [Abstract][Full Text] [Related]
31. Bioinformatics and systems-biology analysis to determine the effects of Coronavirus disease 2019 on patients with allergic asthma.
Fang H; Sun Z; Chen Z; Chen A; Sun D; Kong Y; Fang H; Qian G
Front Immunol; 2022; 13():988479. PubMed ID: 36211429
[TBL] [Abstract][Full Text] [Related]
32. Bioinformatics and system biology approach to identify the influences of COVID-19 on cardiovascular and hypertensive comorbidities.
Nashiry A; Sarmin Sumi S; Islam S; Quinn JMW; Moni MA
Brief Bioinform; 2021 Mar; 22(2):1387-1401. PubMed ID: 33458761
[TBL] [Abstract][Full Text] [Related]
33. The 5% of the Population at High Risk for Severe COVID-19 Infection Is Identifiable and Needs to Be Taken Into Account When Reopening the Economy.
Preskorn SH
J Psychiatr Pract; 2020 May; 26(3):219-227. PubMed ID: 32421292
[TBL] [Abstract][Full Text] [Related]
34. Comorbid conditions and outcomes in patients with pulmonary arterial hypertension: a REVEAL registry analysis.
Poms AD; Turner M; Farber HW; Meltzer LA; McGoon MD
Chest; 2013 Jul; 144(1):169-176. PubMed ID: 23348820
[TBL] [Abstract][Full Text] [Related]
35. Bioinformatics Analysis to Identify Intersection Genes, Associated Pathways and Therapeutic Drugs between COVID-19 and Oral Candidiasis.
Yang L; Yang N; Huang H; Yu J; Sui X; Tao L; Gao Y; Liu Z
Comb Chem High Throughput Screen; 2023; 26(8):1533-1546. PubMed ID: 36214307
[TBL] [Abstract][Full Text] [Related]
36. Drug interaction risk between cardioprotective drugs and drugs used in treatment of COVID-19: A evidence-based review from six databases.
S K SR; P A A; B S; Kalala KP; Pm A; Sabarathinam S
Diabetes Metab Syndr; 2022 Mar; 16(3):102451. PubMed ID: 35279008
[TBL] [Abstract][Full Text] [Related]
37. Integrated Bioinformatics Analysis of Shared Genes, miRNA, Biological Pathways and Their Potential Role as Therapeutic Targets in Huntington's Disease Stages.
Christodoulou CC; Papanicolaou EZ
Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902304
[TBL] [Abstract][Full Text] [Related]
38. Investigation of COVID-19 comorbidities reveals genes and pathways coincident with the SARS-CoV-2 viral disease.
Dolan ME; Hill DP; Mukherjee G; McAndrews MS; Chesler EJ; Blake JA
bioRxiv; 2020 Sep; ():. PubMed ID: 32995795
[TBL] [Abstract][Full Text] [Related]
39. Network-medicine approach for the identification of genetic association of parathyroid adenoma with cardiovascular disease and type-2 diabetes.
Imam N; Alam A; Siddiqui MF; Veg A; Bay S; Khan MJI; Ishrat R
Brief Funct Genomics; 2023 May; 22(3):250-262. PubMed ID: 36790356
[TBL] [Abstract][Full Text] [Related]
40. Molecular association of pathogenetic contributors to pre-eclampsia (pre-eclampsia associome).
Glotov AS; Tiys ES; Vashukova ES; Pakin VS; Demenkov PS; Saik OV; Ivanisenko TV; Arzhanova ON; Mozgovaya EV; Zainulina MS; Kolchanov NA; Baranov VS; Ivanisenko VA
BMC Syst Biol; 2015; 9 Suppl 2(Suppl 2):S4. PubMed ID: 25879409
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
